Catalyst Pharma ( ($CPRX) ) has shared an announcement. On August 25, 2025, Catalyst Pharmaceuticals and its licensor SERB S.A. announced a ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Catalyst Pharmaceuticals (CPRX) announced that the Company and its licensor SERB S.A. have entered into a Settlement Agreement with Lupin Ltd and ...

The new US tariff regime, including a 26% reciprocal rate on India, could pressure the Rupee and key export sectors. Read how businesses can ...

The following is a listing of all home transfers in Burlington County reported from Aug. 18 to Aug. 24. There were 114 ...

Reaching your protein goals, no matter what they are, doesn't have to be exhausting. We spoke to experts about how to ...

Entrepreneurship competition draws over 50,000 applicants each season, culminating in high-stakes outcomes such as 'Most ...

Zee Business Managing Editor Anil Singhvi shares his strategy for the coming session on Dalal Street. Learn more about his ...

RBI Governor Sanjay Malhotra expressed hope that India-US trade talks will reach a positive conclusion. Malhotra's remarks come at a time when the sixth round of India-US Bilateral Trade Agreement ...